Press enter or spacebar to select a desired language.
Gas and Oil
Powered by EBSCO
Press enter or spacebar to select a desired language.

RSS Items

3721 - 3730 of 71479 results found

Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19

Date
Wednesday, March 27, 2024 - 4:00 AM
Description
AZD7442 is a combination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies, tixagevimab and cilgavimab, developed for pre-exposure prophylaxis (PrEP) and treatment of coronavirus disease 2019 (COVID-19). Using